Birdwatch Note Rating
2023-03-17 01:50:20 UTC - SOMEWHAT_HELPFUL
Rated by Participant: 18B51F87481AB31C7A9311DBC6EE8E589128F72866F6B52C7CDBB5CB04304C9B
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details